ABT-510/Thrombospondin-1 mimetic

DRUG2 trials

Sponsors

Abbott

Conditions

Carcinoma, Non-Small-Cell LungCarcinoma, Renal Cell

Phase 2

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

TerminatedNCT00061646

AbbottCarcinoma, Non-Small-Cell Lung

Start: 2003-03-31Updated: 2007-08-14

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

CompletedNCT00073125

AbbottCarcinoma, Renal Cell

Start: 2003-05-31Updated: 2007-08-15